J. Virol., 10 1996, 6694-6700, Vol 70, No. 10
Copyright © 1996, American Society for Microbiology

Activity of purified hepatitis C virus protease NS3 on peptide substrates

C Steinkuhler, A Urbani, L Tomei, G Biasiol, M Sardana, E Bianchi, A Pessi and R De Francesco
Istituto di Ricerche di Biologia Molecolare P. Angeletti Pomezia, Rome, Italy.

The protease domain of the hepatitis C virus (HCV) protein NS3 was expressed in Escherichia coli, purified to homogeneity, and shown to be active on peptides derived from the sequence of the NS4A-NS4B junction. Experiments were carried out to optimize protease activity. Buffer requirements included the presence of detergent, glycerol, and dithiothreitol, pH between 7.5 and 8.5, and low ionic strength. C- and N-terminal deletion experiments defined a peptide spanning from the P6 to the P4' residue as a suitable substrate. Cleavage kinetics were subsequently measured by using decamer P6-P4' peptides corresponding to all intermolecular cleavage sites of the HCV polyprotein. The following order of cleavage efficiency, in terms of kcat/Km, was determined: NS5A- NS5B > NS4A-NS4B >> NS4B-NS5A. A 14-mer peptide containing residues 21 to 34 of the protease cofactor NS4A (Pep4A 21-34), when added in stoichiometric amounts, was shown to increase cleavage rates of all peptides, the largest effect (100-fold) being observed on the hydrolysis of the NS4B-NS5A decamer. From the kinetic analysis of cleavage data, we conclude that (i) primary structure is an important determinant of the efficiency with which each site is cleaved during polyprotein processing, (ii) slow cleavage of the NS4B-NS5A site in the absence of NS4A is due to low binding affinity of the enzyme for this site, and (iii) formation of a 1:1 complex between the protease and Pep4A 21-34 is sufficient and required for maximum activation.

This article has been cited by other articles:

• Svitkin, Y. V., Pause, A., Lopez-Lastra, M., Perreault, S., Sonenberg, N. (2005). Complete Translation of the Hepatitis C Virus Genome In Vitro: Membranes Play a Critical Role in the Maturation of All Virus Proteins except for NS3. J. Virol. 79: 6868-6881 [Abstract] [Full Text]  
• Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M. Jr., Lemon, S. M. (2005). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102: 2992-2997 [Abstract] [Full Text]  
• Niyomrattanakit, P., Winoyanuwattikun, P., Chanprapaph, S., Angsuthanasombat, C., Panyim, S., Katzenmeier, G. (2004). Identification of Residues in the Dengue Virus Type 2 NS2B Cofactor That Are Critical for NS3 Protease Activation. J. Virol. 78: 13708-13716 [Abstract] [Full Text]  
• Wang, W., Lahser, F. C., Yi, M., Wright-Minogue, J., Xia, E., Weber, P. C., Lemon, S. M., Malcolm, B. A. (2004). Conserved C-Terminal Threonine of Hepatitis C Virus NS3 Regulates Autoproteolysis and Prevents Product Inhibition. J. Virol. 78: 700-709 [Abstract] [Full Text]  
• Artsaenko, O., Tessmann, K., Sack, M., Haussinger, D., Heintges, T. (2003). Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies. J. Gen. Virol. 84: 2323-2332 [Abstract] [Full Text]  
• Leung, D., Schroder, K., White, H., Fang, N.-X., Stoermer, M. J., Abbenante, G., Martin, J. L., Young, P. R., Fairlie, D. P. (2001). Activity of Recombinant Dengue 2 Virus NS3 Protease in the Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and Inhibitors. J. Biol. Chem. 276: 45762-45771 [Abstract] [Full Text]  
• Thibeault, D., Maurice, R., Pilote, L., Lamarre, D., Pause, A. (2001). In Vitro Characterization of a Purified NS2/3 Protease Variant of Hepatitis C Virus. J. Biol. Chem. 276: 46678-46684 [Abstract] [Full Text]  
• Schwartz, D. A. (2001). The role of TLR4 in endotoxin responsiveness in humans. Innate Immunity 7: 389-393 [Abstract]  
• Sbardellati, A., Scarselli, E., Amati, V., Falcinelli, S., Kekulé, A. S., Traboni, C. (2000). Processing of GB virus B non-structural proteins in cultured cells requires both NS3 protease and NS4A cofactor. J. Gen. Virol. 81: 2183-2188 [Abstract] [Full Text]  
• Ueno, T., Misawa, S., Ohba, Y., Matsumoto, M., Mizunuma, M., Kasai, N., Tsumoto, K., Kumagai, I., Hayashi, H. (2000). Isolation and Characterization of Monoclonal Antibodies That Inhibit Hepatitis C Virus NS3 Protease. J. Virol. 74: 6300-6308 [Abstract] [Full Text]  
• Fowler, A., Price-Jones, M., Hughes, K., Anson, J., Lingham, R., Schulman, M. (2000). Development of a High Throughput Scintillation Proximity Assay for Hepatitis C Virus NS3 Protease That Reduces the Proportion of Competitive Inhibitors Identified. J Biomol Screen 5: 153-158 [Abstract]  
• Fattori, D., Urbani, A., Brunetti, M., Ingenito, R., Pessi, A., Prendergast, K., Narjes, F., Matassa, V. G., De Francesco, R., Steinkuhler, C. (2000). Probing the Active Site of the Hepatitis C Virus Serine Protease by Fluorescence Resonance Energy Transfer. J. Biol. Chem. 275: 15106-15113 [Abstract] [Full Text]  
• Butkiewicz, N., Yao, N., Zhong, W., Wright-Minogue, J., Ingravallo, P., Zhang, R., Durkin, J., Standring, D. N., Baroudy, B. M., Sangar, D. V., Lemon, S. M., Lau, J. Y. N., Hong, Z. (2000). Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3. J. Virol. 74: 4291-4301 [Abstract] [Full Text]  
• Martin, F., Steinkuhler, C., Brunetti, M., Pessi, A., Cortese, R., De Francesco, R., Sollazzo, M. (1999). A loop-mimetic inhibitor of the HCV-NS3 protease derived from a minibody. Protein Eng Des Sel 12: 1005-1011 [Abstract] [Full Text]  
• LaPlante, S. R., Cameron, D. R., Aubry, N., Lefebvre, S., Kukolj, G., Maurice, R., Thibeault, D., Lamarre, D., Llinas-Brunet, M. (1999). Solution Structure of Substrate-based Ligands When Bound to Hepatitis C Virus NS3 Protease Domain. J. Biol. Chem. 274: 18618-18624 [Abstract] [Full Text]  
• Murthy, H. M. K., Clum, S., Padmanabhan, R. (1999). Dengue Virus NS3 Serine Protease. CRYSTAL STRUCTURE AND INSIGHTS INTO INTERACTION OF THE ACTIVE SITE WITH SUBSTRATES BY MOLECULAR MODELING AND STRUCTURAL ANALYSIS OF MUTATIONAL EFFECTS. J. Biol. Chem. 274: 5573-5580 [Abstract] [Full Text]  
• Filocamo, G., Pacini, L., Nardi, C., Bartholomew, L., Scaturro, M., Delmastro, P., Tramontano, A., De Francesco, R., Migliaccio, G. (1999). Selection of Functional Variants of the NS3-NS4A Protease of Hepatitis C Virus by Using Chimeric Sindbis Viruses. J. Virol. 73: 561-575 [Abstract] [Full Text]  
• Patick, A. K., Potts, K. E. (1998). Protease Inhibitors as Antiviral Agents. Clin. Microbiol. Rev. 11: 614-627 [Abstract] [Full Text]  
• Gallinari, P., Brennan, D., Nardi, C., Brunetti, M., Tomei, L., Steinkuhler, C., De Francesco, R. (1998). Multiple Enzymatic Activities Associated with Recombinant NS3 Protein of Hepatitis C Virus. J. Virol. 72: 6758-6769 [Abstract] [Full Text]  
• Urbani, A., Bazzo, R., Nardi, M. C., Cicero, D. O., De Francesco, R., Steinkuhler, C., Barbato, G. (1998). The Metal Binding Site of the Hepatitis C Virus NS3 Protease. A SPECTROSCOPIC INVESTIGATION. J. Biol. Chem. 273: 18760-18769 [Abstract] [Full Text]  
• Urbani, A., Bianchi, E., Narjes, F., Tramontano, A., De Francesco, R., Steinkuhler, C., Pessi, A. (1997). Substrate Specificity of the Hepatitis C Virus Serine Protease NS3. J. Biol. Chem. 272: 9204-9209 [Abstract] [Full Text]